{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:10Z","timestamp":1781636170853,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cystic Fibrosis is an inherited, life-limiting condition causing a range of symptoms including lowered exercise tolerance. Approximately 95% of people with cystic fibrosis in the United Kingdom are now eligible for new genetic modulator therapies. As a result, cystic fibrosis centres are treating older populations in greater numbers. Cardiopulmonary exercise testing measures aerobic capacity, however it is resource intensive. Identifying whether routinely collected clinical measures are associated with reduced aerobic capacity is needed to aid prioritisation of cardiopulmonary exercise testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Maximal cardiopulmonary exercise testing data were collected from July 2022 to January 2024, alongside routine clinical data (spirometry, body mass index, diabetic status, Pseudomonas aeruginosa colonisation status, modulator status, age and sex). Peak oxygen uptake was analysed as a percentage predicted value (VO\n                      <jats:sub>2peak<\/jats:sub>\n                      pp).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall aerobic capacity at the centre was low (mean peak oxygen uptake 79.16% predicted). No relationship was identified between body mass index and aerobic capacity (\u03b2\u2009=\u20090.23, 95%CI -0.91, 1.37,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.69). When adjusting for other clinical measures, having cystic fibrosis related diabetes (\u03b2=-17.56, 95%CI -27.17, -7.95,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and younger age (\u03b2\u2009=\u200916.62, 95%CI 4.13, 29.12,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) were associated with a reduction in VO\n                      <jats:sub>2peak<\/jats:sub>\n                      pp.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Annual CPET for all pwCF may not be necessary or available. This service evaluation found associations with younger age and CFRD and reduced VO\n                      <jats:sub>2peak<\/jats:sub>\n                      who could be targeted for exercise testing and training intervention in the future.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04164-8","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:04:20Z","timestamp":1771542260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritising cardiopulmonary exercise testing for adults with cystic fibrosis: a service evaluation"],"prefix":"10.1186","volume":"26","author":[{"given":"Rachel","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibueze","family":"Ogbonnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"4","key":"4164_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","volume":"22","author":"A Lopez","year":"2023","unstructured":"Lopez A, et al. Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. J Cyst Fibros. 2023;22(4):607\u201314.","journal-title":"J Cyst Fibros"},{"key":"4164_CR2","unstructured":"Naito Y, Charman S, Duckers J, Clarke S. UK Cystic Fibrosis Registry 2022 Annual Data Report. 2023."},{"key":"4164_CR3","unstructured":"Trust CF. Standards of Care and Good Clinical Practice for the Physiotherapy Management of Cystic Fibrosis. 2020."},{"issue":"1","key":"4164_CR4","doi-asserted-by":"publisher","first-page":"e001121","DOI":"10.1136\/bmjresp-2021-001121","volume":"8","author":"A Pritchard","year":"2021","unstructured":"Pritchard A, et al. ARTP statement on cardiopulmonary exercise testing 2021. BMJ Open Respiratory Res. 2021;8(1):e001121.","journal-title":"BMJ Open Respiratory Res"},{"issue":"8","key":"4164_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1164\/rccm.201806-1110OC","volume":"199","author":"H Hebestreit","year":"2019","unstructured":"Hebestreit H, et al. Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis. Am J Respir Crit Care Med. 2019;199(8):987\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"4164_CR6","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/S1569-1993(23)00813-5","volume":"22","author":"R Young","year":"2023","unstructured":"Young R, Howard S, Bridges C, Sabit R, Duckers J, Ketchell I, Lau D, Addy C. P445 A marathon not a sprint: Establishing a physiotherapist led cystic fibrosis specific cardio pulmonary exercise testing (CPET) service for Wales. J Cyst Fibros. 2023;22:S199.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"4164_CR7","doi-asserted-by":"publisher","first-page":"e000765","DOI":"10.1136\/bmjsem-2020-000765","volume":"6","author":"O Torvanger","year":"2020","unstructured":"Torvanger O, et al. Cardiorespiratory fitness on a treadmill in an adult cystic fibrosis population. BMJ Open Sport Exerc Med. 2020;6(1):e000765.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"4","key":"4164_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000439057","volume":"90","author":"H Hebestreit","year":"2015","unstructured":"Hebestreit H, et al. Statement on exercise testing in cystic fibrosis. Respiration. 2015;90(4):332\u201351.","journal-title":"Respiration"},{"issue":"2","key":"4164_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.167.2.211","volume":"167","author":"ATS\/ACCP","year":"2003","unstructured":"ATS\/ACCP. ATS\/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211\u201377.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4164_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0002-8703(91)91009-C","volume":"122","author":"M Shimizu","year":"1991","unstructured":"Shimizu M, et al. The ventilatory threshold: method, protocol, and evaluator agreement. Am Heart J. 1991;122(2):509\u201316.","journal-title":"Am Heart J"},{"issue":"154","key":"4164_CR11","doi-asserted-by":"publisher","first-page":"180101","DOI":"10.1183\/16000617.0101-2018","volume":"28","author":"T Radtke","year":"2019","unstructured":"Radtke T, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respiratory Rev. 2019;28(154):180101.","journal-title":"Eur Respiratory Rev"},{"key":"4164_CR12","volume-title":"Principles of exercise testing and interpretation","author":"KH Wasserman","year":"2005","unstructured":"Wasserman KH, Sue JE. DY., Principles of exercise testing and interpretation. 4th ed. Philadelphia PA, USA: Lippincott Williams & Wilkin; 2005.","edition":"4"},{"key":"4164_CR13","doi-asserted-by":"crossref","unstructured":"Pallant J. SPSS survival manual: A step by step guide to data analysis using IBM SPSS. Routledge; 2020.","DOI":"10.4324\/9781003117445"},{"issue":"3","key":"4164_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jcf.2024.05.007","volume":"23","author":"A Gramegna","year":"2024","unstructured":"Gramegna A, et al. Standards for the care of people with cystic fibrosis (CF); planning for a longer life. J Cyst Fibros. 2024;23(3):375\u201387.","journal-title":"J Cyst Fibros"},{"key":"4164_CR15","doi-asserted-by":"crossref","unstructured":"Hurley N et al. Factors influencing physical activity in adults with cystic fibrosis. BMC Pulm Med. 2021;21(1):113\u201323","DOI":"10.1186\/s12890-021-01482-x"},{"key":"4164_CR16","doi-asserted-by":"crossref","unstructured":"Tomlinson OW et al. Skeletal muscle contributions to reduced fitness in cystic fibrosis youth. Front Ped. 2023;11:1\u20138.","DOI":"10.3389\/fped.2023.1211547"},{"key":"4164_CR17","first-page":"72","volume":"24","author":"DS Urquhart","year":"2017","unstructured":"Urquhart DS, Vendrusculo FM. Clinical interpretation of cardiopulmonary exercise testing in cystic fibrosis and implications for exercise counselling. Paediatr Respir Rev. 2017;24:72\u20138.","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"4164_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1513\/AnnalsATS.201707-570OC","volume":"15","author":"T Radtke","year":"2018","unstructured":"Radtke T, et al. CFTR genotype and maximal exercise capacity in cystic fibrosis: A Cross-sectional study. Ann Am Thorac Soc. 2018;15(2):209\u201316.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"4164_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/jhn.12906","volume":"35","author":"R Revuelta Iniesta","year":"2022","unstructured":"Revuelta Iniesta R, et al. The impact of plasma 25-hydroxyvitamin D on pulmonary function and exercise physiology in cystic fibrosis: A multicentre retrospective study. J Hum Nutr Diet. 2022;35(2):363\u201375.","journal-title":"J Hum Nutr Diet"},{"issue":"6","key":"4164_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jcf.2013.04.012","volume":"12","author":"ZL Saynor","year":"2013","unstructured":"Saynor ZL, et al. Reproducibility of maximal cardiopulmonary exercise testing for young cystic fibrosis patients. J Cyst Fibros. 2013;12(6):644\u201350.","journal-title":"J Cyst Fibros"},{"key":"4164_CR21","doi-asserted-by":"crossref","unstructured":"Gaupmann R et al. Long-term exercise capacity in paediatric cystic fibrosis: a modern era perspective. ERJ Open Res. 2025;11(4):971\u20131036 .","DOI":"10.1183\/23120541.00971-2024"},{"key":"4164_CR22","doi-asserted-by":"crossref","unstructured":"Frost F, Dilip N, Fauchier L, Wat D, Shelley J, Austin P, Walshaw M, Lip G. Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: A multinational retrospective cohort study. Eur Respir J. 2023:62(4):2300174.","DOI":"10.1183\/13993003.00174-2023"},{"issue":"1","key":"4164_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respiratory Med. 2020;8(1):65\u2013124.","journal-title":"Lancet Respiratory Med"},{"issue":"13","key":"4164_CR24","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1080\/09593985.2021.1973165","volume":"38","author":"J Cardoso","year":"2022","unstructured":"Cardoso J, et al. Relationship between peripheral muscle strength, exercise capacity and body composition in children and adolescents with cystic fibrosis. Physiother Theory Pract. 2022;38(13):3010\u20137.","journal-title":"Physiother Theory Pract"},{"issue":"6","key":"4164_CR25","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1378\/chest.124.6.2215","volume":"124","author":"PH Klijn","year":"2003","unstructured":"Klijn PH, et al. Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest. 2003;124(6):2215\u20139.","journal-title":"Chest"},{"key":"4164_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.rmed.2018.07.016","volume":"142","author":"N Papalexopoulou","year":"2018","unstructured":"Papalexopoulou N, et al. Nutritional status and pulmonary outcome in children and young people with cystic fibrosis. Respir Med. 2018;142:60\u20135.","journal-title":"Respir Med"},{"issue":"5","key":"4164_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcf.2023.06.002","volume":"22","author":"D Proud","year":"2023","unstructured":"Proud D, Duckers J. Weight a minute: exploring the effect on weight and body composition after the initiation of elexacaftor\/tezacaftor\/ivacaftor in adults with CF. J Cyst Fibros. 2023;22(5):847\u201350.","journal-title":"J Cyst Fibros"},{"key":"4164_CR28","doi-asserted-by":"crossref","unstructured":"Snowball JE, et al. A paradigm shift in cystic fibrosis nutritional care: Clinicians\u2019 views on the management of patients with overweight and obesity. Journal of Cystic Fibrosis. 2023;22(5):836\u2013842.","DOI":"10.1016\/j.jcf.2023.03.011"},{"issue":"11","key":"4164_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/thx.2006.061366","volume":"61","author":"JK Block","year":"2006","unstructured":"Block JK, et al. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax. 2006;61(11):969\u201374.","journal-title":"Thorax"},{"issue":"12","key":"4164_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1089\/jwh.2014.4985","volume":"23","author":"CL Harness-Brumley","year":"2014","unstructured":"Harness-Brumley CL, et al. Gender differences in outcomes of patients with cystic fibrosis. J Women\u2019s Health. 2014;23(12):1012\u201320.","journal-title":"J Women\u2019s Health"},{"issue":"3","key":"4164_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s42399-020-00239-7","volume":"2","author":"OW Tomlinson","year":"2020","unstructured":"Tomlinson OW, et al. Challenges in implementing routine cardiopulmonary exercise testing in cystic fibrosis clinical practice: a Single-Centre review. SN Compr Clin Med. 2020;2(3):327\u201331.","journal-title":"SN Compr Clin Med"},{"issue":"3","key":"4164_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcf.2019.09.014","volume":"19","author":"AJ Causer","year":"2020","unstructured":"Causer AJ, et al. The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis. J Cyst Fibros. 2020;19(3):427\u201333.","journal-title":"J Cyst Fibros"},{"issue":"11","key":"4164_CR33","doi-asserted-by":"publisher","first-page":"H1479","DOI":"10.1152\/ajpheart.00136.2016","volume":"310","author":"P Rodriguez-Miguelez","year":"2016","unstructured":"Rodriguez-Miguelez P, et al. Evidence of microvascular dysfunction in patients with cystic fibrosis. Am J Physiol Heart Circ Physiol. 2016;310(11):H1479\u201385.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"4164_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcf.2008.12.002","volume":"8","author":"H White","year":"2009","unstructured":"White H, et al. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention. J Cyst Fibros. 2009;8(3):179\u201385.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"4164_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcf.2022.06.012","volume":"22","author":"T Radtke","year":"2023","unstructured":"Radtke T, et al. Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial. J Cyst Fibros. 2023;22(1):31\u20138.","journal-title":"J Cyst Fibros"},{"key":"4164_CR36","first-page":"28","volume":"27","author":"DS Urquhart","year":"2018","unstructured":"Urquhart DS, Saynor ZL. Exercise testing in cystic fibrosis: who and why? Paediatr Respir Rev. 2018;27:28\u201332.","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"4164_CR37","doi-asserted-by":"publisher","first-page":"e001490","DOI":"10.1136\/bmjsem-2022-001490","volume":"8","author":"OW Tomlinson","year":"2022","unstructured":"Tomlinson OW, Wadey CA, Williams CA. Normal reference values for aerobic fitness in cystic fibrosis: a scoping review. BMJ Open Sport Exerc Med. 2022;8(4):e001490.","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"3","key":"4164_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1513\/AnnalsATS.202304-317OC","volume":"21","author":"T Radtke","year":"2024","unstructured":"Radtke T, et al. Cardiopulmonary exercise testing provides prognostic information in advanced cystic fibrosis lung disease. Ann Am Thorac Soc. 2024;21(3):411\u201320.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"4164_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12887-018-1301-x","volume":"18","author":"J Shelley","year":"2018","unstructured":"Shelley et al. A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals. BMC Pediatr. 2018;18(1):335\u201351.","journal-title":"BMC Pediatr"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04164-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:31:55Z","timestamp":1781634715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04164-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04164-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the project was a service evaluation conducted by members of a clinical team, no ethics approval was required as per Health Research Authority guidelines as defined by the UK Policy Framework for Health and Social Care Research. Cardiff and Vale University Hospital Board trust internal approval was obtained, project code Cystic Fibrosis\/2023-24\/01. No identifiable data were viewed by anyone outside the clinical physiotherapy team, in keeping with the principles of the Data Protection Act 1998. Similarly, patient consent was not required to use patient data for a service evaluation based on routine care as per the Health Research Authority guidelines. The service evaluation adheres to the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}